89bio (ETNB) said late Tuesday it priced its public offering of 11.5 million shares at $8.50 per share, and pre-funded warrants to purchase up to about 3.3 million shares at $8.499 per warrant for gross proceeds of about $125 million.
Underwriters have been granted a 30-day option to purchase up to about 2.2 million shares.
The offering, which was upsized from the initial proposed $100 million offering, is set to close Thursday.
Shares of the company retreated more than 2% in recent premarket activity.
Price: 8.85, Change: -0.20, Percent Change: -2.21
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments